Efficacy, tolerability and safety of the fixed combination of bimatoprost 0.03% and timolol 0.5% in a broad patient population: multicenter, open-label observational study. [electronic resource]
- Current medical research and opinion Apr 2009
- 1037-43 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't